|
It was reported that the interventional procedure was for the treatment of stenosis in the left subclavian artery via the radial artery access site with an 0.035-inch 300cm non-abbott guidewire and a 7fr sheath.A 4x20mm non-abbott device was delivered and inflation of the lesion site was attempted, but the lesion did not dilate.The 9x29mm omnilink elite stent delivery system was initially unable to cross the predilated lesion due to the calcified plaques proximal to the lesion.The 7x20mm armada 35 balloon dilatation catheter (bdc) met resistance during advancement to the lesion, then the armada balloon ruptured with the first inflation at 11 atmospheres due to the calcified plaques.The 7x40mm armada bdc was used as a replacement to further predilate the lesion, then the same 9x29 mm omnilink elite was successfully deployed.Subsequently, an 8x80mm non-abbott device was deployed in the subclavian artery proximal to the lesion and post-dilatation was performed with the 7x40mm armada bdc to complete the procedure.There were no adverse patient effects and there was no reported clinically significant delay in the procedure.No additional information was provided.
|
|
The device was not returned for evaluation.The production record and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.It was reported that the procedure was to treat stenosis in the left subclavian artery.It should be noted that the percutaneous transluminal angioplasty catheter (pta), armada 35/armada 35ll, global, instruction for use states: the device is intended for dilatation of lesions in the renal, iliac, femoral, popliteal, tibial, and peroneal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.In this case, it is unknown if the ifu violation contributed to the reported compliant.The investigation determined the reported complaints appear to be related to operational context.There was no leak noted during preparation, which suggests a product quality issue did not contribute to the reported difficulties.It was reported by the account that the balloon dilatation catheter (bdc) interacted with the heavily calcified anatomy resulting in the difficulty advancing the device.The balloon likely interacted with the challenging anatomy, resulting in the ruptured during inflation.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.H6 - medical device problem code 1494 clarifier - incorrect anatomy.
|